Search research articles
Contact Us
Filters
Showing results (21-30 of 55) with videos related to
Page
of 6
Sort By:
Plos One
|
February 7, 2023
The accuracy of an electronic nose to diagnose tuberculosis in patients referred to an expert centre
Rosarito Coronel Teixeira, Luis Gómez, Eva González, et al.
Pharmaceutics
|
April 28, 2023
Dried Blood Spot Sampling to Assess Rifampicin Exposure and Treatment Outcomes among Native and Non-Native Tuberculosis Patients in Paraguay: An Exploratory Study
Samiksha Ghimire, Gladys Molinas, Arturo Battaglia, et al.
Emerging Infectious Diseases
|
March 8, 2008
Mycobacterium xenopi clinical relevance and determinants, the Netherlands
Jakko van Ingen, Martin J Boeree, Wiel C M de Lange, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
May 21, 2010
[Nontuberculous mycobacteria: clinically relevant]
Jakko van Ingen, Wouter Hoefsloot, Wiel C M de Lange, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society
|
June 25, 2025
<sup>18</sup>F-fluorodeoxyglucose PET/CT scans for thoracic tuberculosis: current evidence and future perspectives
Ana Paula Santos, Rosana Souza Rodrigues, Erik H J G Aarntzen, et al.
Antimicrobial Agents and Chemotherapy
|
August 15, 2018
Minocycline Has No Clear Role in the Treatment of Mycobacterium abscessus Disease
Mike M Ruth, Jasper J N Sangen, Lian J Pennings, et al.
International Journal of Mycobacteriology
|
January 21, 2016
Hypersensitivity pneumonitis caused by Mycobacterium avium subsp. hominissuis in a hot tub, as proven by IS1245 RFLP and rep-PCR typing
Rianne J C van der Zanden, Cecile Magis-Escurra, Wiel C M de Lange, et al.
ERJ Open Research
|
December 2, 2020
Immune defects in patients with pulmonary <i>Mycobacterium abscessus</i> disease without cystic fibrosis
Milou M F Schuurbiers, Mariolina Bruno, Sanne M H Zweijpfenning, et al.
Plos One
|
March 15, 2019
High-dose rifampicin in tuberculosis: Experiences from a Dutch tuberculosis centre
Charlotte Seijger, Wouter Hoefsloot, Inge Bergsma-de Guchteneire, et al.
Respiration; International Review of Thoracic Diseases
|
December 14, 2022
New and Repurposed Drugs for the Treatment of Active Tuberculosis: An Update for Clinicians
Jessica M Aguilar Diaz, Ahmed A Abulfathi, Lindsey Hm Te Brake, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 55) with videos related to
Sort By:
Page
of 6
Plos One
|
February 7, 2023
The accuracy of an electronic nose to diagnose tuberculosis in patients referred to an expert centre
Rosarito Coronel Teixeira, Luis Gómez, Eva González, et al.
Pharmaceutics
|
April 28, 2023
Dried Blood Spot Sampling to Assess Rifampicin Exposure and Treatment Outcomes among Native and Non-Native Tuberculosis Patients in Paraguay: An Exploratory Study
Samiksha Ghimire, Gladys Molinas, Arturo Battaglia, et al.
Emerging Infectious Diseases
|
March 8, 2008
Mycobacterium xenopi clinical relevance and determinants, the Netherlands
Jakko van Ingen, Martin J Boeree, Wiel C M de Lange, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
May 21, 2010
[Nontuberculous mycobacteria: clinically relevant]
Jakko van Ingen, Wouter Hoefsloot, Wiel C M de Lange, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society
|
June 25, 2025
<sup>18</sup>F-fluorodeoxyglucose PET/CT scans for thoracic tuberculosis: current evidence and future perspectives
Ana Paula Santos, Rosana Souza Rodrigues, Erik H J G Aarntzen, et al.
Antimicrobial Agents and Chemotherapy
|
August 15, 2018
Minocycline Has No Clear Role in the Treatment of Mycobacterium abscessus Disease
Mike M Ruth, Jasper J N Sangen, Lian J Pennings, et al.
International Journal of Mycobacteriology
|
January 21, 2016
Hypersensitivity pneumonitis caused by Mycobacterium avium subsp. hominissuis in a hot tub, as proven by IS1245 RFLP and rep-PCR typing
Rianne J C van der Zanden, Cecile Magis-Escurra, Wiel C M de Lange, et al.
ERJ Open Research
|
December 2, 2020
Immune defects in patients with pulmonary <i>Mycobacterium abscessus</i> disease without cystic fibrosis
Milou M F Schuurbiers, Mariolina Bruno, Sanne M H Zweijpfenning, et al.
Plos One
|
March 15, 2019
High-dose rifampicin in tuberculosis: Experiences from a Dutch tuberculosis centre
Charlotte Seijger, Wouter Hoefsloot, Inge Bergsma-de Guchteneire, et al.
Respiration; International Review of Thoracic Diseases
|
December 14, 2022
New and Repurposed Drugs for the Treatment of Active Tuberculosis: An Update for Clinicians
Jessica M Aguilar Diaz, Ahmed A Abulfathi, Lindsey Hm Te Brake, et al.
Page
of 6